The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sodium Nitroprusside
Sodium Nitroprusside · SODIUM NITROPRUSSIDE 50 mg/2mL · Injection, Solution · Intravenous · Dr.Reddy's Laboratories Inc.,
NDC 43598-0587-23 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 2 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$20.00
Reported to Texas DSHS · 2026 annual filing · Dr. Reddy's Laboratories, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA210114
- TE code
- AP
- Approval date
- Apr 10, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sodium Nitroprusside (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Exela Pharma Sciences, Llc | SODIUM NITROPRUSSIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Exela Pharma Sciences, Llc | SODIUM NITROPRUSSIDE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hainan Poly Pharm. Co., Ltd. | SODIUM NITROPRUSSIDE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | SODIUM NITROPRUSSIDE 50 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr.Reddy's Laboratories Inc., | SODIUM NITROPRUSSIDE 50 mg/2mL | Jul 15, 2026 | Aug 31, 2026 |
| Hainan Poly Pharm. Co., Ltd. | SODIUM NITROPRUSSIDE .2 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Sodium Nitroprusside — NDC 43598-0587-23," retrieved September 3, 2026, https://drugdashboards.com/drug/43598058723.
Free to cite with attribution — see how the data is put together.